HYPE Could See Upward Momentum After Sonnet BioTherapeutics Launches $583M Hyperliquid Treasury
2025-07-16 22:30:18

Main Idea
Sonnet BioTherapeutics and Rorschach's launch of a $583M Hyperliquid treasury could drive HYPE token's price above $50, supported by strong corporate backing and market indicators.
Key Points
1. Hyperliquid Strategies Inc. will hold 12.6 million HYPE tokens and a $305 million cash reserve, potentially influencing HYPE's price dynamics.
2. Technical analysis shows HYPE's RSI approaching overbought territory, with potential for a breakout above $50 if support at $45.80 holds.
3. A drop below the 20-day exponential moving average ($42.93) or 50-day simple moving average ($38.86) could lead to a deeper correction.
4. The $583 million treasury launch by a Nasdaq-listed biotech firm reflects growing institutional interest in crypto assets.
5. The initiative combines large token holdings with corporate treasury strategies, signaling broader market maturity and potential for HYPE's price growth.
Description
Are You Chasing New Coins? Catch the newest crypto opportunities. Be the first to buy, be the first to win! Click here to discover new altcoins! Sonnet BioTherapeutics’ strategic
Latest News
- Canary Capital Files Staked Injective ETF in Delaware, Potentially Enhancing Altcoin Investment Access2025-07-17 17:24:36
- BlackRock Seeks Approval for Ethereum ETF Including Staking Rewards, Potentially Paving Way for Yield-Generating Crypto Funds2025-07-17 17:23:27
- Bitcoin’s 4-Year Cycle Appears Intact with Potential Peaks Expected in Late 2025, Suggests CryptoCon2025-07-17 17:03:13
- BitMine Immersion Nears $1 Billion in Ethereum Holdings as It Expands ETH Treasury Strategy2025-07-17 17:01:43
- BLACKROCKS APPLIES TO ADD STAKING TO ITS ETHEREUM ETF2025-07-17 17:01:24